Abstract
AIM: To quantify the relation between apparent treatment resistant hypertension (aTRH) and the risk of recurrent major adverse cardiovascular events (MACE including stroke, myocardial infarction and vascular death) and mortality in patients with stable vascular disease. METHODS: 7455 hypertensive patients with symptomatic vascular disease were included from the ongoing UCC-SMART
... read more